Form 4: PROCEPT BioRobotics Director Larry Wood Boosts Equity Holdings with RSU and Stock Option Grants

PROCEPT BioRobotics Corp. Director Larry L. Wood has increased his beneficial ownership in the company through the acquisition of Restricted Stock Units (RSUs) and stock options, aligning his interests further with shareholders.

Summary

• Larry L. Wood, a Director of PROCEPT BioRobotics Corp. (PRCT), acquired 1,538 shares of Common Stock in the form of Restricted Stock Units (RSUs) on June 10, 2025, at a price of $0.
• Each RSU represents a contingent right to receive one share of Common Stock and will vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Additionally, Mr. Wood was granted 2,771 stock options on June 10, 2025, with an exercise price of $64.23 per share, also at a price of $0 for the grant itself.
• These stock options will vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Following these transactions, Mr. Wood beneficially owns 5,968 shares of Common Stock and 2,771 stock options.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director is increasing their equity stake in the company, which generally signals confidence and aligns their interests with shareholders. This is a routine compensation event for a director.

Positives

• The acquisition of RSUs and stock options by Director Larry L. Wood demonstrates increased alignment of management and director interests with those of shareholders.
• Equity grants at a $0 acquisition price for the RSU and option grant itself provide a strong incentive for the director to contribute to the company's long-term success and share price appreciation.

Risks

• The vesting of both the Restricted Stock Units and stock options is subject to Larry L. Wood's continued service through the applicable vesting date, meaning the benefits are contingent on his ongoing tenure.

Future Outlook

The equity grants to Director Larry L. Wood are designed to incentivize his continued service and align his financial interests with the long-term performance and growth of PROCEPT BioRobotics Corp. The vesting schedule ties his compensation to future company milestones or continued tenure.

Industry Context

This Form 4 filing is a standard disclosure of insider equity transactions, common across all industries, particularly in high-growth sectors like medical robotics where equity compensation is a key tool for attracting and retaining talent and aligning interests.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants to a director can be viewed positively as they align the director's financial incentives with the company's stock performance, potentially leading to more shareholder-friendly decisions.
• Employees: While not directly impacting all employees, such compensation structures for leadership can set a precedent for performance-based incentives within the company.

Next Steps

• The Restricted Stock Units and stock options will vest on the earlier of the one-year anniversary of the grant date (June 10, 2026) or the date of the next annual meeting following the grant date, subject to continued service.

Key Dates

Keywords

PROCEPT BioRobotics, PRCT, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Options, Equity Compensation, Director Compensation, Beneficial Ownership, Corporate Governance